Drug intelligence / Profile preview

ivy leaf extract

Development stage: Phase 3
Lead developer: AHN-GOOK PHARMACEUTICAL
Administration: Oral

Overview

Ivy leaf extract, derived from Hedera helix L., is a herbal medicine primarily used for respiratory conditions such as coughs, bronchitis, and acute upper respiratory tract infections. Its therapeutic effects are mainly attributed to triterpene saponins, particularly alpha-hederin and hederacoside C. It acts as an expectorant, mucolytic, bronchodilator, and possesses anti-inflammatory properties. The extract helps to thin and loosen mucus, making it easier to expel, and relaxes bronchial muscles, improving airflow. It also reduces inflammation in the respiratory tract. Ahn-Gook Pharmaceuticals Co., Ltd. is involved in developing products containing ivy leaf extract.

Brand names: Prospan
Other names: Hedera helix L. extractEnglish ivy leaf extractivy leaves dry extract

Targets

NF-κBADRB2 (β2)IL-6 (Interleukin 6)

Beyond the preview

Go deeper on ivy leaf extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ivy leaf extract.

Explore the full profile